Back
ESC Professional Premium Access

Medication adherence assessment and reporting in cardiovascular randomised controlled trials

Session: Cardiovascular epidemiology & trial design
Topic: Trial Design
Speaker: Doctor Z. Ashkir (Oxford, GB)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Zakariye Ashkir

University of Oxford Centre for Clinical Magnetic Resonance Research, Oxford (United Kingdom of Great Britain & Northern Ireland)
1 follower

5 more presentations in this session

Accuracy of event rate and effect size estimation in major cardiovascular trials

Speaker: Assistant Professor C. Olivier (Freiburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

AT-RISK: AuToimmune disorders and cardiovascular RISK.

Speaker: Doctor N. Conrad (Leuven, BE)

Access
Abstract
Slides
Video
Like
Thumbnail

Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry

Speaker: Doctor V. Arevalos Rivas (Barcelona, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

The REALITY project: analysis of a national database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain.

Speaker: Professor V. Barrios (Madrid, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Development of a risk prediction score and equation for chronic kidney disease: A retrospective cohort study

Speaker: Doctor S. Kawasoe (Kagoshima, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiovascular epidemiology & trial design

Speakers: Doctor Z. Ashkir, Assistant Professor C. Olivier, Doctor N. Conrad, Doctor V. Arevalos Rivas, Professor V. Barrios...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources